Published in Infect Immun on November 01, 2005
Virulence and immunomodulatory roles of bacterial outer membrane vesicles. Microbiol Mol Biol Rev (2010) 3.27
Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza. Clin Vaccine Immunol (2006) 2.01
Vaccines for gonorrhea: can we rise to the challenge? Front Microbiol (2011) 1.16
Immunization with Salmonella enterica serovar Typhimurium-derived outer membrane vesicles delivering the pneumococcal protein PspA confers protection against challenge with Streptococcus pneumoniae. Infect Immun (2010) 1.04
NERVE: new enhanced reverse vaccinology environment. BMC Biotechnol (2006) 0.97
Population dynamics of Neisseria gonorrhoeae in Shanghai, China: a comparative study. BMC Infect Dis (2010) 0.93
Identification and characterization of gonococcal iron transport systems as potential vaccine antigens. Future Microbiol (2008) 0.85
Vaccination with major outer membrane protein proteosomes elicits protection in mice against a Chlamydia respiratory challenge. Microbes Infect (2013) 0.79
Neisseria gonorrhoeae NspA induces specific bactericidal and opsonic antibodies in mice. Clin Vaccine Immunol (2011) 0.78
Enhancement of protein expression by alphavirus replicons by designing self-replicating subgenomic RNAs. Proc Natl Acad Sci U S A (2014) 0.78
Passive immunization with a polyclonal antiserum to the hemoglobin receptor of Haemophilus ducreyi confers protection against a homologous challenge in the experimental swine model of chancroid. Infect Immun (2011) 0.77
Saturating mutagenesis of an essential gene: a majority of the Neisseria gonorrhoeae major outer membrane porin (PorB) is mutable. J Bacteriol (2013) 0.76
Gonorrhea - an evolving disease of the new millennium. Microb Cell (2016) 0.75
Oral Immunization of Rabbits with S. enterica Typhimurium Expressing Neisseria gonorrhoeae Filamentous Phage Φ6 Induces Bactericidal Antibodies Against N. gonorrhoeae. Sci Rep (2016) 0.75
Antibodies with higher bactericidal activity induced by a Neisseria gonorrhoeae Rmp deletion mutant strain. PLoS One (2014) 0.75
Predominant porB1A and porB1B genotypes and correlation of gene mutations with drug resistance in Neisseria gonorrhoeae isolates in Eastern China. BMC Infect Dis (2010) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
NEISSERIA GONORRHOEAE. I. VIRULENCE GENETICALLY LINKED TO CLONAL VARIATION. J Bacteriol (1963) 45.03
From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect (1999) 17.95
A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Biotechnology (N Y) (1991) 7.08
Serological classification of Neisseria gonorrhoeae with monoclonal antibodies. Infect Immun (1982) 5.54
Characterization of serologically dominant outer membrane proteins of Neisseria gonorrhoeae. J Bacteriol (1980) 4.65
Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Virology (1997) 3.62
A community-based outbreak of infection with penicillin-resistant Neisseria gonorrhoeae not producing penicillinase (chromosomally mediated resistance). N Engl J Med (1985) 2.85
Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis. J Virol (2000) 2.67
Genetics of protein I of Neisseria gonorrhoeae: construction of hybrid porins. Proc Natl Acad Sci U S A (1988) 2.27
Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins. Virology (1995) 2.14
Monoclonal antibodies against Neisseria gonorrhoeae: production of antibodies directed against a strain-specific cell surface antigen. Infect Immun (1981) 2.09
Epidemiologic evidence for the development of serovar-specific immunity after gonococcal infection. J Clin Invest (1989) 1.98
Human experimentation with Neisseria gonorrhoeae: rationale, methods, and implications for the biology of infection and vaccine development. J Infect Dis (1994) 1.88
Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice. Infect Immun (1999) 1.86
Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex. Vaccine (1997) 1.83
Antibodies to N-terminal peptides of gonococcal porin are bactericidal when gonococcal lipopolysaccharide is not sialylated. Mol Microbiol (1992) 1.66
Molecular typing of Neisseria gonorrhoeae causing repeated infections: evolution of porin during passage within a community. J Infect Dis (1999) 1.62
Protection against infection with Neisseria meningitidis group B serotype 2b by passive immunization with serotype-specific monoclonal antibody. Infect Immun (1985) 1.60
A method for the efficient blotting of strongly basic proteins from sodium dodecyl sulfate-polyacrylamide gels to nitrocellulose. Anal Biochem (1985) 1.59
Gonococcal salpingitis is less likely to recur with Neisseria gonorrhoeae of the same principal outer membrane protein antigenic type. Am J Obstet Gynecol (1980) 1.56
Alphavirus replicon particles as candidate HIV vaccines. IUBMB Life (2002) 1.41
Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles. J Virol (2002) 1.36
Mechanism of action of blocking immunoglobulin G for Neisseria gonorrhoeae. J Clin Invest (1985) 1.35
Intracellular survival of Neisseria gonorrhoeae in male urethral epithelial cells: importance of a hexaacyl lipid A. Infect Immun (2002) 1.34
Construction of isogenic gonococci with variable porin structure: effects on susceptibility to human serum and antibiotics. Mol Microbiol (1990) 1.30
Longitudinal evaluation of serovar-specific immunity to Neisseria gonorrhoeae. Am J Epidemiol (1999) 1.26
Monoclonal antibodies directed against gonococcal protein I vary in bactericidal activity. J Immunol (1985) 1.22
Gonococcal invasion of epithelial cells driven by P.IA, a bacterial ion channel with GTP binding properties. J Exp Med (1998) 1.17
Characterization of native outer membrane vesicles from lpxL mutant strains of Neisseria meningitidis for use in parenteral vaccination. Infect Immun (2005) 1.17
Monoclonal antibodies to gonococcal outer membrane protein IB: use in investigation of the potential protective effect of antibodies directed against conserved and type-specific epitopes. J Gen Microbiol (1986) 1.15
Mutagenesis of the Neisseria gonorrhoeae porin reduces invasion in epithelial cells and enhances phagocyte responsiveness. Mol Microbiol (1999) 1.10
Boswell's gonorrhea. Bull N Y Acad Med (1969) 1.08
The potential protective effect of monoclonal antibodies to gonococcal outer membrane protein IA. J Gen Microbiol (1987) 1.03
Immunobiology of purified recombinant outer membrane porin protein I of Neisseria gonorrhoeae. Mol Microbiol (1994) 1.03
Immune protection against staphylococcal enterotoxin-induced toxic shock by vaccination with a Venezuelan equine encephalitis virus replicon. J Infect Dis (2002) 1.01
Discontinuation of cefixime tablets--United States. MMWR Morb Mortal Wkly Rep (2002) 0.99
Vaccines for gonorrhea: where are we on the curve? Trends Microbiol (1995) 0.98
T lymphocyte response to Neisseria gonorrhoeae porin in individuals with mucosal gonococcal infections. J Infect Dis (1999) 0.97
DNA immunization of mice with a plasmid encoding Neisseria gonorrhea PorB protein by intramuscular injection and epidermal particle bombardment. Vaccine (2004) 0.96
Intranasal immunization with gonococcal outer membrane preparations reduces the duration of vaginal colonization of mice by Neisseria gonorrhoeae. J Infect Dis (2000) 0.93
Vaccine-induced IgG antibodies to the linear epitope on the PorB outer membrane protein promote opsonophagocytosis of Neisseria meningitidis by human neutrophils. Clin Immunol Immunopathol (1997) 0.85
Immunobiology of gonococcal outer membrane protein I. Antonie Van Leeuwenhoek (1987) 0.84
Meningococcal outer membrane vesicle vaccine given intranasally can induce immunological memory and booster responses without evidence of tolerance. Infect Immun (2001) 0.83
Modulation of the biological activities of meningococcal endotoxins by association with outer membrane proteins is not inevitably linked to toxicity. Infect Immun (1997) 0.82
Characterization of a subunit structure and stability of the recombinant porin from Neisseria gonorrhoeae. J Protein Chem (1998) 0.78
Novel Treponema pallidum serologic tests: a paradigm shift in syphilis screening for the 21st century. Clin Infect Dis (2010) 3.04
The emerging threat of untreatable gonococcal infection. N Engl J Med (2012) 2.85
Neisseria gonorrhoeae activates the proteinase cathepsin B to mediate the signaling activities of the NLRP3 and ASC-containing inflammasome. J Immunol (2009) 2.09
Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice. Proc Natl Acad Sci U S A (2008) 1.97
Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains. Vaccine (2006) 1.74
Heterotypic humoral and cellular immune responses following Norwalk virus infection. J Virol (2009) 1.70
Expression and self-assembly of norwalk virus capsid protein from venezuelan equine encephalitis virus replicons. J Virol (2002) 1.60
Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-kappaB signaling. J Virol (2009) 1.58
Effects of PKR/RNase L-dependent and alternative antiviral pathways on alphavirus replication and pathogenesis. Viral Immunol (2002) 1.56
Mucosal and systemic adjuvant activity of alphavirus replicon particles. Proc Natl Acad Sci U S A (2006) 1.49
Golden hamsters are nocturnal in captivity but diurnal in nature. Biol Lett (2008) 1.44
Species status of Neisseria gonorrhoeae: evolutionary and epidemiological inferences from multilocus sequence typing. BMC Biol (2007) 1.44
Alphavirus replicon particles as candidate HIV vaccines. IUBMB Life (2002) 1.41
Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles. J Virol (2002) 1.36
An attenuating mutation in nsP1 of the Sindbis-group virus S.A.AR86 accelerates nonstructural protein processing and up-regulates viral 26S RNA synthesis. J Virol (2003) 1.35
Correlation between env V1/V2 region diversification and neutralizing antibodies during primary infection by simian immunodeficiency virus sm in rhesus macaques. J Virol (2004) 1.32
Experimental Gonococcal Infection in Male Volunteers: Cumulative Experience with Neisseria gonorrhoeae Strains FA1090 and MS11mkC. Front Microbiol (2011) 1.26
Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats. J Virol (2007) 1.24
A novel viral system for generating antigen-specific T cells. J Immunol (2005) 1.21
A mutant form of the Neisseria gonorrhoeae pilus secretin protein PilQ allows increased entry of heme and antimicrobial compounds. J Bacteriol (2004) 1.20
Venezuelan equine encephalitis virus disrupts STAT1 signaling by distinct mechanisms independent of host shutoff. J Virol (2009) 1.19
Alphavirus-adjuvanted norovirus-like particle vaccines: heterologous, humoral, and mucosal immune responses protect against murine norovirus challenge. J Virol (2009) 1.17
Recognition of familiar individuals in golden hamsters: a new method and functional neuroanatomy. J Neurosci (2005) 1.16
Vaccines for gonorrhea: can we rise to the challenge? Front Microbiol (2011) 1.16
Vaccination of macaques with SIV immunogens delivered by Venezuelan equine encephalitis virus replicon particle vectors followed by a mucosal challenge with SIVsmE660. Vaccine (2005) 1.14
Opposing selective forces for expression of the gonococcal lactoferrin receptor. Mol Microbiol (2003) 1.10
Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models. Vaccine (2003) 1.10
Role of humoral versus cellular responses induced by a protective dengue vaccine candidate. PLoS Pathog (2013) 1.04
Comparison of multiple vaccine vectors in a single heterologous prime-boost trial. Vaccine (2008) 1.03
Ribosomal protein S6 associates with alphavirus nonstructural protein 2 and mediates expression from alphavirus messages. J Virol (2006) 1.03
The role of the blood-brain barrier during Venezuelan equine encephalitis virus infection. J Virol (2011) 1.01
Alphavirus replicon particles acting as adjuvants promote CD8+ T cell responses to co-delivered antigen. Vaccine (2008) 0.99
Lipid A's structure mediates Neisseria gonorrhoeae fitness during experimental infection of mice and men. MBio (2013) 0.99
Medial amygdala involvement in discrimination of same-species and closely-related-species male stimuli in estrous female Mesocricetus hamsters. Behav Neurosci (2009) 0.98
An alphavirus replicon-based human metapneumovirus vaccine is immunogenic and protective in mice and cotton rats. J Virol (2008) 0.98
Early restriction of alphavirus replication and dissemination contributes to age-dependent attenuation of systemic hyperinflammatory disease. J Gen Virol (2007) 0.97
Alphaviral vector-transduced dendritic cells are successful therapeutic vaccines against neu-overexpressing tumors in wild-type mice. Vaccine (2007) 0.97
Individual recognition after fighting by golden hamsters: a new method. Physiol Behav (2002) 0.96
An immunogenic and protective alphavirus replicon particle-based dengue vaccine overcomes maternal antibody interference in weanling mice. J Virol (2007) 0.95
A two-phase innate host response to alphavirus infection identified by mRNP-tagging in vivo. PLoS Pathog (2007) 0.95
Alphavirus replicon-based adjuvants enhance the immunogenicity and effectiveness of Fluzone ® in rhesus macaques. Vaccine (2010) 0.95
Modulation of type I IFN induction by a virulence determinant within the alphavirus nsP1 protein. Virology (2010) 0.94
T cells facilitate recovery from Venezuelan equine encephalitis virus-induced encephalomyelitis in the absence of antibody. J Virol (2010) 0.93
Nonmucosal alphavirus vaccination stimulates a mucosal inductive environment in the peripheral draining lymph node. J Immunol (2008) 0.92
Alphavirus replicon-based enhancement of mucosal and systemic immunity is linked to the innate response generated by primary immunization. Vaccine (2010) 0.92
Acute infection with venezuelan equine encephalitis virus replicon particles catalyzes a systemic antiviral state and protects from lethal virus challenge. J Virol (2009) 0.92
Vaccination of mice with gonococcal TbpB expressed in vivo from Venezuelan equine encephalitis viral replicon particles. Infect Immun (2006) 0.92
Sampling port for real-time analysis of bioaerosol in whole body exposure system for animal aerosol model development. J Pharmacol Toxicol Methods (2010) 0.92
Vaccination with Venezuelan equine encephalitis replicons encoding cowpox virus structural proteins protects mice from intranasal cowpox virus challenge. Virology (2007) 0.91
Replicon particles of Venezuelan equine encephalitis virus as a reductionist murine model for encephalitis. J Virol (2009) 0.91
Recognition of competitors by male golden hamsters. Physiol Behav (2004) 0.91
Identification of early interactions between Francisella and the host. Infect Immun (2014) 0.91
Heterologous gene expression by infectious and replicon vectors derived from tick-borne encephalitis virus and direct comparison of this flavivirus system with an alphavirus replicon. J Gen Virol (2005) 0.89
Increased immunogenicity of a DNA-launched Venezuelan equine encephalitis virus-based replicon DNA vaccine. J Virol (2007) 0.88
Dominant-subordinate relationships in hamsters: sex differences in reactions to familiar opponents. Horm Behav (2006) 0.88
Infected dendritic cells are sufficient to mediate the adjuvant activity generated by Venezuelan equine encephalitis virus replicon particles. Vaccine (2012) 0.88
Patterns of neural activation associated with exposure to odors from a familiar winner in male golden hamsters. Horm Behav (2004) 0.87
Evaluation of Venezuelan Equine Encephalitis (VEE) replicon-based Outer surface protein A (OspA) vaccines in a tick challenge mouse model of Lyme disease. Vaccine (2003) 0.86
Teaching for quality: where do we go from here? Am J Med Qual (2014) 0.85
Avoidance of interspecific mating in female Syrian hamsters is stronger toward familiar than toward unfamiliar heterospecific males. Learn Behav (2011) 0.85
Fluoxetine does not prevent interspecific mating between two hamster species. Physiol Behav (2010) 0.85
Mutation of the conserved calcium-binding motif in Neisseria gonorrhoeae PilC1 impacts adhesion but not piliation. Infect Immun (2013) 0.84
Discrimination of social odors and their locations: role of lateral entorhinal area. Physiol Behav (2004) 0.84
Adult female hamsters require long and sustained exposures to heterospecific males to avoid interspecific mating. Evol Ecol (2011) 0.84
Adult female hamsters avoid interspecific mating after exposure to heterospecific males. Behav Ecol Sociobiol (2010) 0.84
Kin recognition by self-referent phenotype matching: weighing the evidence. Anim Cogn (2003) 0.84
Point mutations in HpuB enable gonococcal HpuA deletion mutants to grow on hemoglobin. J Bacteriol (2002) 0.83
Diagnosis of neurosyphilis: New tools. Sex Transm Dis (2010) 0.83
Nuclear import and export of Venezuelan equine encephalitis virus nonstructural protein 2. J Virol (2007) 0.83
Highly excited and exotic meson spectrum from dynamical lattice QCD. Phys Rev Lett (2009) 0.82
Ultra-low dose of Mycobacterium tuberculosis aerosol creates partial infection in mice. Tuberculosis (Edinb) (2011) 0.82
Male hamsters discriminate estrous state from vaginal secretions and individuals from flank marks. Behav Processes (2009) 0.82
Attenuation of Sindbis virus variants incorporating uncleaved PE2 glycoprotein is correlated with attachment to cell-surface heparan sulfate. Virology (2004) 0.82
Experiences with new generation vaccines against equine viral arteritis, West Nile disease and African horse sickness. Vaccine (2007) 0.81
Non-agonistic familiarity decreases aggression in male Turkish hamsters, Mesocricetus brandti. Anim Behav (2009) 0.81
A strategy for reduction of antibiotic use in new patients admitted to a neonatal intensive care unit. Pediatr Neonatol (2012) 0.80
Structure and immunogenicity of alternative forms of the simian immunodeficiency virus gag protein expressed using Venezuelan equine encephalitis virus replicon particles. Virology (2007) 0.78
Early activation of the host complement system is required to restrict central nervous system invasion and limit neuropathology during Venezuelan equine encephalitis virus infection. J Gen Virol (2011) 0.78
The immunosuppressive tumor environment is the major impediment to successful therapeutic vaccination in Neu transgenic mice. J Immunother (2010) 0.77
Treatment of medical students during clerkships based on their stated career interests. Teach Learn Med (2003) 0.77
A novel self-replicating chimeric lentivirus-like particle. J Virol (2011) 0.76
Syphilis management in St. Petersburg, Russia: 1995-2001. Sex Transm Dis (2006) 0.76